HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christopher R Garrett Selected Research

BMS188797

1/2006Phase I study of the taxane BMS-188797 in combination with carboplatin administered every 3 weeks in patients with solid malignancies.
5/2005Phase I study of a novel taxane BMS-188797 in adult patients with solid malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christopher R Garrett Research Topics

Disease

21Neoplasms (Cancer)
01/2018 - 05/2005
11Colorectal Neoplasms (Colorectal Cancer)
01/2018 - 01/2006
3Exanthema (Rash)
02/2015 - 02/2007
3Rectal Neoplasms (Rectal Cancer)
02/2014 - 01/2012
3Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
06/2012 - 08/2007
3Adenocarcinoma
01/2012 - 10/2007
3Neoplasm Metastasis (Metastasis)
10/2011 - 01/2006
2Fatigue
02/2015 - 10/2006
2Carcinogenesis
04/2014 - 09/2007
2Disease Progression
06/2012 - 02/2007
1Diabetes Mellitus
01/2018
1Diarrhea
02/2015
1Stomatitis
02/2015
1Inflammation (Inflammations)
04/2014
1Hepatocellular Carcinoma (Hepatoma)
04/2014
1Pathologic Complete Response
02/2013
1Hemorrhage
11/2009
1Abdominal Pain (Pain, Abdominal)
11/2009
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
11/2009
1Lymphoma (Lymphomas)
11/2008
1Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2008
1Necrosis
11/2008
1Prostatic Neoplasms (Prostate Cancer)
11/2008
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2008
1Breast Neoplasms (Breast Cancer)
08/2008
1Stomach Neoplasms (Stomach Cancer)
08/2008
1Barrett Esophagus (Barrett's Esophagus)
10/2007
1Adenoma (Adenomas)
09/2007
1Nausea
10/2006
1Febrile Neutropenia
05/2005

Drug/Important Bio-Agent (IBA)

5Cetuximab (Erbitux)FDA Link
03/2015 - 02/2007
3Biomarkers (Surrogate Marker)IBA
06/2012 - 09/2009
2Metformin (Glucophage)FDA LinkGeneric
01/2018 - 02/2013
2Irinotecan (Camptosar)FDA LinkGeneric
03/2015 - 12/2013
2ErbB Receptors (EGF Receptor)IBA
01/2013 - 12/2008
2Imatinib Mesylate (Gleevec)FDA Link
06/2012 - 09/2009
2Sunitinib (Sutent)FDA Link
06/2012 - 09/2009
2Proteins (Proteins, Gene)FDA Link
12/2011 - 08/2008
2triciribineIBA
10/2007 - 09/2007
2API 2IBA
10/2007 - 09/2007
2Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
10/2007 - 09/2007
2taxaneIBA
01/2006 - 05/2005
2BMS188797IBA
01/2006 - 05/2005
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2018
1Phosphotransferases (Kinase)IBA
10/2015
1EverolimusFDA Link
03/2015
1MK 2206IBA
02/2015
1AZD 6244IBA
02/2015
1Lipase (Acid Lipase)FDA Link
02/2015
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
02/2015
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
04/2014
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
04/2014
1Erlotinib Hydrochloride (CP 358,774)FDA Link
02/2014
1Bevacizumab (Avastin)FDA Link
02/2014
1Capecitabine (Xeloda)FDA Link
02/2014
1Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2013
1EZN-2208IBA
12/2013
1Carcinoembryonic AntigenIBA
02/2013
1Calcibiotic Root Canal SealerIBA
01/2013
1Monoclonal AntibodiesIBA
01/2013
1triciribine phosphateIBA
12/2011
1Topoisomerase I InhibitorsIBA
07/2011
1thiamine triphosphorate (TTP)IBA
09/2009
1Tyrosine Kinase InhibitorsIBA
09/2009
1Panitumumab (Vectibix)FDA Link
12/2008
1Pharmaceutical PreparationsIBA
12/2008
1AntibodiesIBA
12/2008
1CreatinineIBA
11/2008
1Hormones (Hormone)IBA
11/2008
1Docetaxel (Taxotere)FDA Link
11/2008
1Prostate-Specific Antigen (Semenogelase)IBA
11/2008
1sepantroniumIBA
11/2008
1Cyclin D1IBA
08/2008
1Staphylococcal Protein A (Protein A)IBA
08/2008
1Epidermal Growth Factor (EGF)IBA
08/2008
1Coloring Agents (Dyes)IBA
09/2007
1EpiregulinIBA
08/2007
1LigandsIBA
08/2007
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
08/2007
1Growth Factor ReceptorsIBA
08/2007
1AmphiregulinIBA
08/2007
1Canertinib (CI 1033)IBA
08/2006
1Carboplatin (JM8)FDA LinkGeneric
01/2006
1Paclitaxel (Taxol)FDA LinkGeneric
01/2006

Therapy/Procedure

10Therapeutics
10/2015 - 01/2006
5Drug Therapy (Chemotherapy)
10/2011 - 01/2006
2Radiotherapy
02/2014 - 11/2009
1Ovariectomy (Oophorectomy)
09/2012
1Re-Irradiation
11/2009
1Intravenous Infusions
11/2008
1Metastasectomy
01/2006